Downstream Processing Featured Articles

  1. Next-Generation Kinetex Calculator From Phenomenex Customizes Core-Shell HPLC/UHPLC Method Creation 11/30/2011
    Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces the next-generation Kinetex Calculator – an online tool that generates customized, optimized Kinetex methods for HPLC or UHPLC systems.
  2. GE Healthcare Life Sciences Launches Capto™ L Chromatography Medium For Capture Of Antibodies And Antibody Fragments 5/8/2012

    GE Healthcare’s Capto L affinity chromatography medium (resin) is designed for the purification of antibody fragments. It combines a rigid, high-flow agarose matrix with the immunoglobulin-binding recombinant protein L ligand, which has strong affinity for the variable region of antibody’s kappa light chain.

  3. Pittcon 2013 Conference Tackles Life Sciences Challenges, Novel Research 2/7/2013

    Pittcon has always been the premiere venue for companies to launch new products and for scientists to present their latest research to a global audience.

  4. iBio, Inc. And GE Healthcare Form New Global Alliance 7/26/2012

    iBio, Inc., and GE Healthcare, the healthcare business of GE, announced recently a new global alliance to commercialize plant-based technologies for the manufacture of biopharmaceuticals and vaccines.

  5. Saint-Gobain Introduces Sani-Tech® Ultra 6/27/2012

    Saint-Gobain Performance Plastics continues its long tradition of innovation in ultra-pure tubing technology with new Sani-Tech® Ultra. This platinum-cured silicone tubing meets the stringent requirements of demanding biopharmaceutical process applications while delivering improved performance in a number of areas.

  6. Combo Of Avastin, Second Drug Shows Promise Fighting Brain Cancer, Mayo Clinic Finds 2/14/2013

    The drug bevacizumab, also known by the trade name Avastin, shrinks tumors briefly in patients with an aggressive brain cancer known as glioblastoma multiforme, but then they often grow again and spread throughout the brain for reasons no one previously has understood.

  7. WHO Member States Make Progress On Noncommunicable Diseases 11/12/2012

    The first-ever global monitoring framework to combat several of the world’s biggest killers has been agreed this week by WHO Member States. The framework comprises nine voluntary global targets and 25 indicators to prevent and control diseases such as heart disease, diabetes, cancer, chronic lung disease and other noncommunicable diseases.

  8. WHEATON Announces Acquisition Of CELLine 7/9/2012

    WHEATON has acquired the CELLine dual membrane, cell culture flasks from Wilson Wolf Manufacturing Corporation.  WHEATON has also entered into a long term strategic partnership with Wilson Wolf Manufacturing Corporation for further product development in high density cell culture devices for the production of concentrated, cell secreted products.

  9. New Monoclonal Antibody Developed That Can Target Proteins Inside Cancer Cells 3/13/2013

    Researchers have discovered a unique monoclonal antibody that can effectively reach inside a cancer cell, a key goal for these important anticancer agents, since most proteins that cause cancer or are associated with cancer are buried inside cancer cells.

  10. New Objective And McKinley Scientific Announce A Strategic Co-Marketing Collaboration In High-Performance LC-MS 11/27/2012

    McKinley Scientific, LLC and New Objective, Inc. recently announced that they have entered into a strategic co-marketing and development agreement designed to enable and expand key applications for delivery of high-performance LC-MS systems.